Suchergebnisse - "Mehta, Monica"

PubPharm (6)

1

Outcomes Associated with De-escalation of Antibiotics to Target Positive Cultures when Treating Febrile Neutropenia

enthalten in: Journal of pharmacy practice | 2024

von Rainess, R. | Campbell, P. | Santamala, J. | +2

2

Thinking Beyond Orbital Cellulitis

enthalten in: Clinical pediatrics | 2022

von Assatourian, L. | Chang, M. | Mehta, M. | +1

3

Successive Emergence of Ceftazidime-Avibactam Resistance through Distinct Genomic Adaptations in blaKPC-2-Harboring Klebsiella pneumoniae Sequence Type 307 Isolates

enthalten in: Antimicrobial agents and chemotherapy | 2018

von Giddins, M. | Macesic, N. | Annavajhala, M. | +6

4

Knowledge, Attitudes, and Practices Regarding Antimicrobial Use and Stewardship Among Prescribers at Acute-Care Hospitals

enthalten in: Infection control and hospital epidemiology | 2018

von Salsgiver, E. | Bernstein, D. | Simon, M. | +11

5

Reply to Aitken et al., "Should Piperacillin-Tazobactam Be Used as Definitive Therapy against Enterobacteriaceae Harboring Inducible AmpC β-Lactamases?"

enthalten in: Antimicrobial agents and chemotherapy | 2017

von Cheng, L. | Nelson, B. | Mehta, M. | +3

CommentOn: Antimicrob Agents Chemother. 2017 May 24;61(6):. - PMID 28320724

6

Piperacillin-Tazobactam versus Other Antibacterial Agents for Treatment of Bloodstream Infections Due to AmpC β-Lactamase-Producing Enterobacteriaceae

enthalten in: Antimicrobial agents and chemotherapy | 2017

von Cheng, L. | Nelson, B. | Mehta, M. | +7

CommentIn: Antimicrob Agents Chemother. 2017 Aug 24;61(9):. - PMID 28839082

1
[1]